Nanogami
Private Company
Funding information not available
Overview
Nanogami is pioneering a horizontal biochip framework using DNA origami to precisely place sensor molecules and signal-amplifying nanostructures at scale. Its technology platform targets the core challenges of biochip performance—throughput, sensitivity, specificity, and cost—across genomics, transcriptomics, and proteomics applications. As a private, early-stage platform company, Nanogami is seeking industry partners to collaborate on developing customized biochips, positioning itself as an enabler for the broader life sciences and diagnostics industry.
Technology Platform
Proprietary DNA origami technology to create nanostructured breadboards that precisely place sensor molecules and signal-amplifying features for integration into ultra-high-density, customizable biochips.
Opportunities
Risk Factors
Competitive Landscape
Competitors include established providers of microarray and biochip surfaces (e.g., Illumina, Thermo Fisher, Agilent) and other DNA nanotechnology startups. Nanogami differentiates by combining single-molecule placement precision with integrated signal amplification and a focus on a customizable, industry-spanning framework rather than a single product.